Double Autologous Stem Cell Transplantation Significantly Prolongs ...

Double autologous stem cell transplantation significantly prolongs progression-free survival and overall survival in comparison with single autotransplantation.

The role of single vs double autologous stem cell transplantation (ASCT) for newly diagnosed (ND) multiple myeloma (MM) continues to be debated in the novel ...

Think Twice: Doubling Back to Tandem Autologous Stem Cell ...

Double autologous stem cell transplantation significantly prolongs progression-free survival and overall survival in comparison with single autotransplantation ...

Comparison of single and double autologous stem cell ... - NCBI

Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we ...

European Study Shows Double Transplant Improves Survival in ...

Double autologous stem cell transplantation (ASCT) significantly prolongs progression-free and overall survival, vs single transplant, according to the phase ...

Current status of autologous stem cell transplantation for multiple ...

The analysis demonstrated no significant difference in progression-free survival (PFS), OS, or treatment-related mortality between the two ...

Single versus Double Autologous Stem-Cell Transplantation for ...

As compared with a single transplantation, double transplantation prolonged ... significantly from the second transplantation (P=0.70) (Figure 3A). Figure ...

Double Autologous Stem Cell Transplantation Significantly Prolongs ...

Background The role of single vs double autologous stem cell transplantation (ASCT) for newly diagnosed (ND) multiple myeloma (MM) continues ...

Tandem Autologous Stem Cell Transplantation Improves Outcomes ...

22. Cavo, M. ∙ Gay, F.M. ∙ Patriarca, F. ... Double autologous stem cell transplantation significantly prolongs progression-free survival and overall ...

Double Vs Single Autologous Stem Cell Transplantation for Newly ...

Conversely, in the high-risk subgroup assignment to ASCT-2 significantly prolonged both PFS (median: 32 vs 20 mos, HR 0.71, CI 0.54-0.93, p ...

Impact of second autologous stem‐cell transplantation at relapsed ...

A second autologous stem-cell transplantation (ASCT2) is considered for relapsed multiple myeloma (RMM) patients showing prolonged response ...

Comparative analysis of single versus tandem autologous stem cell ...

Tandem transplantation was associated with significantly improved PFS after adjusting for maintenance therapy in patients with ISS III, those with high-risk ...

Comparison of single and double autologous stem cell ... - De Gruyter

Background Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) ...

Superiority of Double over Single Autologous Stem-Cell ...

In comparison with a single autotransplantation, double ASCT resulted in a significant ... Prolonged OS was significantly related to ...

Autologous Transplantation and Maintenance Therapy in Multiple ...

Consolidation therapy with high-dose melphalan plus stem-cell transplantation, as compared with MPR, significantly prolonged progression-free ...

Is there still a role for stem cell transplantation in multiple myeloma?

3, 4 In both trials, high-dose chemotherapy and ASCT significantly prolonged progression-free survival (PFS) and OS in comparison with standard- ...

Role of Stem Cell Transplantation in Multiple Myeloma - MDPI

Due to significant peripheral neuropathy and sedation associated with prolonged ... double autologous stem-cell transplantation for multiple myeloma ...

Real-world advantage and challenge of post-autologous stem cell ...

Despite similar rates of MRD-negativity post-ASCT, patients with ≥ 2 HRCA, termed “double hit” (DH), had a significantly higher risk of progression/mortality.

Autologous Stem Cell Transplant during first complete remission ...

The authors concluded that survival of patients with Double-Hit Lymphoma achieving CR1 is not significantly prolonged by Autologous Stem ...

Post-Transplant Maintenance Treatment Options in Multiple Myeloma

Maintenance therapy post autologous stem cell transplant (ASCT) is commonly employed in myeloma patients to prolong remission, as relapse invariably occurs ...